Skip to main content

Early day motion tabled by primary sponsor Baroness Featherstone (Liberal Democrat), on Thursday, 25 January 2007, in the House of Commons. It is signed by 56 members in total.


AFFORDABLE MEDICINES FOR THE DEVELOPING WORLD

That this House notes with concern that the European company Novartis, the makers of the anti-leukaemia drug Glivec, has brought a case against the Indian government to prevent manufacturers of generic medicines from producing low-cost copies of that drug; further notes that the generic medicines produced in India are essential treatments for many people in the developing world, especially those living with HIV/AIDS, and that millions of people rely on drugs produced in India for affordable medicines; and therefore urges Novartis to withdraw its action.


Secondary information

Type
Early day motion
Reference
753 
Session
2006-07
Other sponsors
Simon Hughes
David Howarth
Jo Swinson
Jenny Willott
Willie Rennie
Subjects
Developing countries Drugs India Novartis
Link
View this Early day motion on www.parliament.uk